GLUTAMINE REDUCES CYTOKINE RELEASE, ORGAN DAMAGE, AND MORTALITY IN A RAT MODEL OF ENDOTOXEMIA
The DOI matches its Crossref record.
Abstract
Clinical trials have demonstrated that glutamine (GLN) supplementation can decrease infectious morbidity and improve survival in a number of settings of critical illness. The mechanism of this protection remains unclear. The objective of this study was to evaluate the effect of GLN on cytokine release, organ injury, and survival from endotoxin-induced septic shock. Endotoxemia was induced in Male Sprague-Dawley rats by intravenous administration of 5 mg/kg Escherichia coli lipopolysaccharide (LPS). Concomitantly, animals were fluid resuscitated with a lactated ringers (LR) solution and given GLN (0.75 g/kg i.v.) or LR alone. Blood samples were obtained at multiple time points post-LPS injury for cytokine analysis. Survival rates were monitored for 72 h. Organ injury was evaluated in a separate set of animals via pathologic exam of tissues harvested 6 h post-LPS injury. A single dose of GLN significantly attenuated the release of TNF-alpha at 2 h (P < 0.005) and IL-1 beta at 4 h (P < 0.0001). This attenuation of cytokine release was associated with a significant decrease in mortality (P < 0.003). Pathologic exam demonstrated significant protection of both lung and small bowel tissue by GLN. Blood gas values 6-h post-LPS injury showed increased PaO2 and bicarbonate concentration in GLN treated animals. These data indicate that GLN can significantly attenuate pro-inflammatory cytokine release, protect against end-organ damage, and decrease mortality from endotoxemia. GLN confers protection even when administered at the onset of endotoxemia, rather then as pre-treatment. Thus, one explanation for the clinical benefits observed from GLN-supplementation may be related to the attenuation of pro-inflammatory cytokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Wischmeyer, P. E., Lynch, J., Liedel, J., Wolfson, R., Riehm, J., Gottlieb, L., & Kahana, M. (2001) · Critical Care Medicine · doi:10.1097/00003246-200111000-00006 · Cited by 320
Self-citationGlutamine: Mode of action in critical illness
Wischmeyer, P. E. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000278064.32780.d3 · Cited by 141
“Previous literature has examined the role of Gln in regulating the immune response (18, 31, 32).”
BackgroundSelf-citationPharmaconutrition Review: Physiological Mechanisms
Pierre, J. F., Heneghan, A. F., Lawson, C. M., Wischmeyer, P. E., Kozar, R. A., & Kudsk, K. A. (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607113493326 · Cited by 51
Self-citationThe Role of Glutamine Homeostasis in Emotional and Cognitive Functions
Baek, J. H., Park, H., Kang, H., Kim, R., Kang, J. S., & Kim, H. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021302 · Cited by 35
“However, in both animals and humans, Gln supplementation attenuates inflammation and reduces the release of pro-inflammatory cytokines, such as TNF-α , IL-1 β , and IL-6 [80,81].”
Background
Metadata
- Authors
- Wischmeyer, P. E., Kahana, M., Wolfson, R., Ren, H., Musch, M. M., & Chang, E. B.
- Venue
- Shock
- Published
- 2001-11
- Volume
- 16
- Issue
- 5
- Pages
- 398-402
- ISSN
- 1073-2322 (ISSN-L)
- OpenAlex
- W2072352066
- Cited by
- 162
- References
- 0
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: GLUTAMINE REDUCES CYTOKINE RELEASE, ORGAN DAMAGE, AND MORTALITY IN A RAT MODEL OF ENDOTOXEMIA. https://app.cochat.ai/papers/10.1097/00024382-200116050-00014
- The paper
- Wischmeyer, P. E., Kahana, M., Wolfson, R., Ren, H., Musch, M. M., & Chang, E. B. (2001). GLUTAMINE REDUCES CYTOKINE RELEASE, ORGAN DAMAGE, AND MORTALITY IN A RAT MODEL OF ENDOTOXEMIA. Shock. https://doi.org/10.1097/00024382-200116050-00014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.